FAST MONEY FEATURES
FAST MONEY POLLGet in the post game. Respond to our
"Question of the Day" right now.
TRADER RADAR Which stock should be on your screen? Follow the clues to solve this puzzle.
TRADE SCHOOLGrab a pencil because school is in session and the Fast Money traders are teaching class.
EMERGING MONEY TOP 20
Fast Money's index for the world.
FAST MONEY PODCASTSDownload Fast Money onto your MP3 Player.
FAST MONEY WIDGETGrab this all-in-one application and get recaps of the show sent right to your desktop or blog.
SHOP FOR FAST MONEY MERCHANDISEGet your game on with Fast Money gear.
FAST MONEY PHOTOS!Check out our scrapbook. These "pix" are guaranteed winners.
NEWSLETTERSign up and receive a recap email every Friday after the show!
FAST MONEY MOBILE ALERTSGet advanced information about the next Fast Money.
 |
First, the Food and Drug Administration has posted new proposed guidelines for pre-and post-market testing of the controversial devices.
And Abbott (ABT) is waiting for FDA approval of its drug-coated device which Boston Scientific (BSX) will also get to sell under a different brand name.
On Fast Money Huckman explains that at the conference, Merck (MRK) and Schering-Plough (SGP) are expected to present test results on their controversial drug, Vytorin.
Merck will also present data on weight-loss and heart drugs in its pipeline.
Also Bristol-Myers Squibb's (BMY) Plavix and Eli Lilly's (LLY) experimental blood thinner are in head-to-head study.
How can you trade it?
I think it’s all about Vytorin, says Pete Najarian. If doctors start using this drug Merck and Schering-Plough should profit. Also Merck has a cholesterol drug in its pipeline which could be big. But I like Lilly best, he says, for their diabetes drugs.
Read More:
> Pharma’s Market with Mike Huckman
Check Out These Other Posts |
______________________________________________________
Got something to say? Send us an e-mail at and your comment might be posted on the Rapid Recap! Prefer to keep it between us? You can still send questions and comments to .
Trader disclosure: On Mar.27, 2008, the following stocks and commodities mentioned or intended to be mentioned on CNBC’s Fast Money were owned by the Fast Money traders; Macke Owns (YHOO), (DIS), (INTC); Finerman Owns (GS); Finerman's Firm Owns (DSW), (MSFT), (SUN), (TSO), (VLO), (WMT), (YHOO), (NYX), (PM-WI); Finerman's Firm Is Short (IYR), (IJR), (IWM), (MDY), (SPY); Najarian Owns (BKC), (MSFT), (NOK), (ORCL), (TSO), (XLF), (YHOO), (AAPL); Najarian Owns (AA) Calls, (CCU) Calls, (COP) Calls, (NVDA) Calls, (BSC) Calls, (CHK) Calls; Najarian Owns (LEH) Puts, (MER) Puts, (USB) Puts, (OIH) Puts; Seymour Owns (CFC), (F), (MER), (MSFT), (TMA), (AAPL), (TSO); Seygem Asset Management Owns (TSM); Charles Schwab Is A Sponsor Of "Fast Money"
Del.icio.us
Digg It
Data is a real-time snapshot *Data is delayed at least 15 minutes